Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Gold Up, Regains Shine Despite Vaccine Approval Retreat

Published 12/02/2020, 11:12 PM
Updated 12/02/2020, 11:14 PM
© Reuters.

© Reuters.

By Gina Lee

Investing.com – Gold was up on Thursday morning in Asia, regaining its shine even after news of the first approval for a COVID-19 vaccine saw a retreat from the safe-haven asset. Investors are also keeping an eye on developments for the latest U.S. stimulus measures.

Gold futures were up 0.44% at $1,838.20 by 12:10 AM ET (4:10 AM GMT), remaining above the $1,800 mark.

The U.K.’s Medicines and Healthcare products Regulatory Agency became the first regulator globally to approve a COVID-19 vaccine. It green-lighted BNT162b2, the vaccine candidate jointly developed by BioNTech SE (F:22UAy) and Pfizer Inc (NYSE:PFE), on Wednesday.

The U.S.’ FDA is set to meet for an advisory committee meeting in the following week, and developer Moderna (NASDAQ:MRNA) Inc is also awaiting clearance for its candidate mRNA-1273 in the U.S. and Europe.

Meanwhile, a fresh $908 billion bipartisan proposal is slowly gaining traction as the starting point for Republicans and Democrats to pass the latest stimulus measures, ahead of a Dec. 11 deadline after which the government will shut down.

However, Treasury Secretary Steven Mnuchin and U.S. President Donald Trump have expressed support for a separate proposal put forth by Republican Senate Majority Leader Mitch McConnell after he rejected the $908 billion package.

Federal Reserve Chair Jerome Powell reiterated on Wednesday, during a second day of testimony before the Senate Banking Committee, that there were no hard feelings between the Fed and Mnuchin over the latter’s sunsetting of emergency lending programs in November.

The Fed and the European Central Bank are both due to convene for their respective policy meetings, the last for 2020, in the following week.

Latest comments

just usd weakness
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.